NCT05851092View on ClinicalTrials.gov

Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

May 26, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Advanced Malignant Tumor

Interventions

DRUG

HRS-2189 Tablets

HRS-2189 Tablets

Trial Locations (1)

150081

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY